Internal Medicine, Pulmonary Disease · Boynton Beach, FL
NPI
1669596201
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2623 S Seacrest Blvd, Suite 214
Boynton Beach, FL, 33435
Phone (561) 731-2269
Groups this clinician bills Medicare through
Medicare paid, 2024
$466K
6,625 services
Medicare patients, 2024
1,629
Average age 79
Drug cost, 2024
$2.1M
4,400 prescriptions
Company payments, 2025
$2,735
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fernando A Keller was code 99214 (office e&m - established), 1,439 times for 739 patients. In total Fernando A Keller billed 6,625 services in 44 codes, and Medicare paid $466K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,439 | 739 | $103.49 | $149K |
| 99213 Office E&M - Established | Office | 1,350 | 857 | $71.62 | $97K |
| 99232 Hospital E&M - Subsequent | Facility | 1,078 | 269 | $67.07 | $72K |
| 71046 X-ray - Chest | Office | 384 | 283 | $26.86 | $10K |
| 99204 Office E&M - New | Office | 268 | 268 | $137.23 | $37K |
| 94664 E&M - Miscellaneous | Office | 252 | 245 | $15.13 | $3,812 |
| 94060 Pulmonary Function Testing | Office | 247 | 244 | $32.05 | $7,916 |
| 94726 Pulmonary Function Testing | Office | 228 | 225 | $45.85 | $10K |
| 99222 Hospital E&M - Initial | Facility | 228 | 196 | $111.07 | $25K |
| 94729 Pulmonary Function Testing | Office | 227 | 224 | $45.82 | $10K |
| 99203 Office E&M - New | Office | 203 | 203 | $83.81 | $17K |
| 99457 E&M - Miscellaneous | Office | 121 | 18 | $40.08 | $4,850 |
| 99454 E&M - Miscellaneous | Office | 90 | 13 | $38.67 | $3,481 |
| 94729 Pulmonary Function Testing | Facility | 67 | 66 | $7.29 | $488 |
| 94060 Pulmonary Function Testing | Facility | 67 | 66 | $8.37 | $561 |
By year: 2022 $434K for 6,121 services; 2023 $445K for 6,227 services; 2024 $466K for 6,625 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 52 | 38 | $8.65 | $450 |
Medicare prescription drug claims, 2024
In 2024, the drug Fernando A Keller prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 497 prescriptions and refills. In total Fernando A Keller wrote 4,400 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 497 | 565 | 169 | $13K |
| Breo Ellipta Fluticasone/Vilanterol | 433 | 609 | 105 | $233K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 398 | 581 | 82 | $359K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 332 | 512 | 74 | $226K |
| Prednisone Generic | 278 | 335 | 151 | $1,553 |
| Arnuity Ellipta Fluticasone Furoate | 195 | 253 | 60 | $58K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 141 | 212 | 31 | $97K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 140 | 223 | 50 | $22K |
| Montelukast Sodium Generic | 119 | 345 | 42 | $2,054 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 108 | 153 | 32 | $15K |
| Ventolin Hfa Albuterol Sulfate | 101 | 121 | 34 | $7,879 |
| Cefuroxime Cefuroxime Axetil | 94 | 94 | 81 | $1,018 |
| Azelastine Hcl Generic | 88 | 150 | 38 | $2,535 |
| Fluticasone Propionate Generic | 82 | 168 | 42 | $1,133 |
| Ipratropium Bromide Generic | 67 | 91 | 22 | $2,998 |
Brand drugs: 2,406 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fernando A Keller $2,735 ($2,735 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $853.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $853 |
| Verona Pharma, Inc. VRNA | 27 | $317 |
| GlaxoSmithKline, LLC. GSK | 13 | $307 |
| Actelion Pharmaceuticals US, Inc. JNJ | 6 | $262 |
| Insmed, Inc. INSM | 11 | $210 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $172 |
| Genzyme Corporation SNY | 6 | $146 |
| United Therapeutics Corporation UTHR | 3 | $92.02 |
| Inspire Medical Systems, Inc. INSP | 2 | $72.53 |
| Azurity Pharmaceuticals, Inc. | 2 | $47.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.